[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@KelseyHard10948 Avatar @KelseyHard10948 Miles Jane

Miles Jane posts on X about $vktx, $asts, $aifu, $vik the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance stocks technology brands automotive brands

Social topic influence $vktx #8, $asts, $aifu, $vik, ai, $150m, $bgm, level, money, headed

Top accounts mentioned or mentioned by @mooreroger10 @ripster47 @tenetresearch @tenetcharts @peruvianbull @sjauksuuup4131 @gctdck @bmsinvests @bavariaron

Top assets mentioned Viking Therapeutics, Inc (VKTX) AST SpaceMobile, Inc. Class A Common Stock (ASTS) Viking Holdings Ltd (VIK) Qilian International Holding Group Ltd. Class A Ordinary Shares (BGM) Oracle Corporation (ORCL) NVIDIA Corp. (NVDA) Amazon.com, Inc. (AMZN) Microsoft Corp. (MSFT) Tesla, Inc. (TSLA) Novo-Nordisk (NVO) Amgen, Inc. (AMGN) Eli Lilly and Company (LLY) Ondas Holdings Inc. Common Stock (ONDS)

Top Social Posts

Top posts by engagements in the last XX hours

"$VKTX You dont drop $150M on manufacturing unless the people behind the scenes have a very high level of conviction. Nothing is ever XXX% certain but this is about as close to certain as youll ever see in biotech. Money talks and this kind of upfront spend says they know where this is headed. Also Watching : $BGM $VKTX $AIFU $ASTS"
X Link 2025-12-08T06:20Z XXX followers, XXX engagements

"$VKTX People keep acting like Viking is secretly planning to go it alone. Theyre not. And theyve never said they would. The CEO is a co-founder and hes repeated the same line over and over: We want a partner. Not subtle. Not ambiguous. Straight from the source. And lets be real BL stands to make hundreds of millions if Viking lands the right partnership or buyout. Hes financially aligned with shareholders more than anyone else. He has every incentive to secure the best deal on the table because no one benefits more than he does if VKTX wins big. If you actually listen to the calls the message"
X Link 2025-12-08T12:08Z XXX followers, XXX engagements

"$ORCL dips after earnings and suddenly everyone turns into a bubble expert. AI is done. Stock is dead. Bankruptcy coming. Crash incoming. Same script every time and if they were right $NVDA $MSFT $AMZN $TSLA would all be trading at XX cents by now. Earnings are one chapter not the whole book. Some quarters miss. Some crush. A red print doesnt equal a dying company sometimes its the cleanest entry youll get. Hold a week You usually see a bounce. Hold a month 2030% returns arent rare at all look at past reactions from $META $AAPL $CRM. Real strategy Stay calm. Ignore the panic. Use the dip like"
X Link 2025-12-11T11:17Z XXX followers, XXX engagements

"$VKTX just dropped a sleeper bombshell and most people on X arent paying attention. VK2809 crushed the Phase 2b data XX weeks biopsy-confirmed NASH resolution real fibrosis improvement plus insane lipid wins. Thats the kind of profile $LLY $NVO $AMGN dream about when they talk metabolic pipelines. Phase X is coming but heres the twist: VKTX basically said they dont want to run a full biopsy-confirmed Phase X alone. They want a partner. And if FDA ever lets FibroScan replace biopsy Game changes overnight. The whole NASH sector ( $MDGL $ALT $VRTX $BGM) gets repriced. Watching: $ASTS $AIFU $VKTX"
X Link 2025-12-01T11:38Z XXX followers, 5905 engagements

"$VKTX If you actually run the math on P2A VK2735 oral the 75mg dose implies XXX% WL in just XX weeks. Why Because the 60mg and 90mg ranges already point straight to it. Stretch that to XX weeks (not even XX like $GPCR) youre looking at 15%+ WL potential. And thats P3-confirmation-incoming territory. Yes the 120mg arm had XX% discontinuation but placebo was 18%. Thats a XX% delta with an aggressive schedule. Future P3 dosing 2575mg + slower titration tolerability issue solved. Everything still says the same thing: VK2735 remains best-in-class. $LLY $NVO $AMGN $BGM $QQQ"
X Link 2025-12-09T11:59Z XXX followers, 2644 engagements

"$POET government shutdown and fake AI bubble scare dropped this unnecessarily. Anyone who grabbed some in the $4s was handed a gift. I think were back in $8-9 territory in the next 2-3 weeks. $ASTS $AIFU $ONDS"
X Link 2025-12-10T13:45Z XXX followers, XXX engagements

"$VKTX Dont forget the floor is still $15B based on the MTSR deal. GPCR got rerated today. That doesnt mean GPCR VKTX. It means VKTX hasnt rerated to fair value yet. VK2735 is as derisked as a Phase X agent can be. This is the perfect entry. Why isnt it up Who cares. Bears chatter doesnt matter. X WL is best-in-class X Tolerability best-in-class (PO may beat tirzepatide subq) X Only one with competitive subq oral potential X Stock undervalued Extremely bullish. $NVO $SMCI $AIFU $TSLA $AMGN $BGM"
X Link 2025-12-09T09:40Z XXX followers, 1133 engagements

"$VKTX just got a major tailwind from Washington. The bipartisan SAFE Drugs Act of 2025 could crack down on compounded GLP-1 weight loss drugs the ones that have been causing dosing errors and sourcing issues overseas. FDA already has 1000+ adverse reports tied to these compounding companies. Thats a huge positive for Viking. Meanwhile the shorts who keep shouting its over are running out of ammunition. Policy safety and fundamentals all align if youre long $VKTX this just got a lot more interesting. Watching: $AIFU $VKTX $NVO"
X Link 2025-12-11T12:39Z XXX followers, 1464 engagements